MUFG Securities Americas’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
MUFG Securities Americas's MRNA Position: Q2 2026 in Review
MUFG Securities Americas increased its Moderna (MRNA) stake by 11% in Q2 2026, buying an estimated $52.5K and bringing the position to 10,637 shares worth $745K. The position accounts for 0.04% of the portfolio, ranked #352.
MUFG Securities Americas first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- MUFG Securities Americas held 10,637 shares of Moderna worth $745K as of Q2 2026.
- MUFG Securities Americas bought 1,015 Moderna shares in Q2 2026, an estimated $52.5K.
- Moderna made up 0.04% of MUFG Securities Americas's portfolio in Q2 2026, its #352 holding.
- MUFG Securities Americas first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.